Bond.az White LogoBond.az Black Logo

BTIG Reiterates Neutral on Affirm Stock

BTIG reiterates Neutral on Affirm stock amid credit trends. Analysis of delinquencies, growth prospects, and analyst targets.

Zoe Allen
ByZoe Allen- Senior Editor
|
0

BTIG reiterated a Neutral stock rating on Affirm Holdings (NASDAQ: AFRM), citing mixed signals in the company's April trust data. The stock is currently trading at $65.22 with a market cap of $21.84 billion.

Early-stage delinquencies in the 30-59 day category declined month-over-month across all vintages. However, the 2025-X2 vintage shows elevated early-stage delinquency rates compared to historical norms, raising concerns.

BTIG noted that the higher delinquency rate may be intentional, as Affirm expects revenue less transaction costs (RLTC) margins to compress from above 4.0% due to higher loss expectations. This could allow Affirm to approve more loans and boost gross merchandise volume (GMV).

The strategy remains viable if RLTC margins stay within 3.75%-4.00% while GMV grows above 30% year-over-year. Affirm has demonstrated strong revenue growth of 32% over the last twelve months and turned profitable with diluted EPS of $1.06.

BTIG does not expect Affirm to loosen underwriting further to drive GMV growth, as this could push RLTC margins below guidance. The market should not expect significant beat-and-raise outcomes for GMV going forward.

In other news, Affirm integrated its BNPL options into Google Search and Gemini app via Google Pay. Compass Point raised its price target to $80, Mizuho to $100, Evercore ISI to $90, and Citizens to $85.

More News
2026-06-01 12:02
|
743

Legend Biotech Buy Rating Reiterated

H.C. Wainwright reiterated its Buy rating for Legend Biotech with a $50 target. Revenue up 56% over twelve months.

0
2026-06-01 12:01
|
475

Cogent Stock Price Target Raised to $55

Cogent Biosciences PEAK trial: combination therapy shows 45.6% response rate, 16.5 months PFS, FDA accepts NDA. H.C. Wainwright raises price target to $55.

0
2026-06-01 12:00
|
842

H.C. Wainwright Reaffirms Mineralys Buy

H.C. Wainwright reiterated a Buy rating on Mineralys Therapeutics with a $56 price target after positive trial data.

0
2026-06-01 10:33
|
714

Goldman Sachs Upgrades Marriott Vacations Stock

Goldman Sachs upgrades Marriott Vacations stock to Buy, price target $100. Execution potential drives earnings upside.

0
2026-06-01 10:32
|
730

Goldman Sachs Upgrades Travel + Leisure Stock to Buy

Goldman Sachs upgraded Travel + Leisure stock to Buy with a $85 price target. Learn about the company's financials, dividends, and market outlook.

0
2026-06-01 10:32
|
238

Canaccord Initiates Rare Earths Americas with Buy

Canaccord Genuity initiates Rare Earths Americas with a buy rating and $25 target. Stock at $21.85, offering 14% upside potential.

0
2026-06-01 10:30
|
651

BofA Raises Icon Stock Target to $125 on Bookings

BofA Securities raised Icon plc price target to $125, maintains Underperform. Improved booking trends and Q4 results drive revision.

0
2026-06-01 10:03
|
748

RBC Capital: Sprouts faces Kroger risk

RBC Capital keeps Sprouts rating but sees risks from Kroger price cuts. Analysis and outlook on Bond.az.

0
2026-06-01 09:02
|
551

CLSA Rates Chagee Hold on Margins

CLSA initiated Chagee Holdings with Hold rating and $10 target. Bond.az analysis reveals stock may be undervalued. Read more.

0
2026-06-01 08:31
|
594

Barclays Downgrades Sensata Stock on Valuation

Barclays downgrades Sensata stock to Equalweight on valuation concerns, but raises price target to $53. Stock surged 92% in past year.

0
2026-06-01 08:05
|
946

UBS Initiates Veritone Coverage with Neutral

UBS initiated coverage on Veritone with a Neutral rating and $2.50 price target. The AI company is better positioned for growth after transformation.

0
2026-06-01 08:02
|
892

JMP Securities Initiates Microsoft with Outperform on AI Strategy

JMP Securities initiates Microsoft with Market Outperform rating and $550 target on AI strategy. Revenue growth expected to reach 17% in FY2026.

0
...
BTIG Reiterates Neutral on Affirm Stock | Bond.az